Loading clinical trials...
Loading clinical trials...
A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.
Conditions
Interventions
Obagi New-Derm System
Standard of Care
Locations
9
United States
Suite 135
Oxnard, California, United States
Suite 175
Rancho Santa Margarita, California, United States
Aesthetic and Plastic Surgery Institute
Greeley, Colorado, United States
Brevard Plastic Surgery and Skin Institute
Melbourne, Florida, United States
Kentucky Aesthetic and Plastic Surgery Institute
Louisville, Kentucky, United States
Center for Plastic and Reconstructive Surgery
Ypsilanti, Michigan, United States
Last Updated
April 30, 2010
Lead Sponsor
The Plastic Surgery Foundation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions